DOCSLIB.ORG

Controversies in the Management of Digital Mucous Cysts

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Controversies in the Management of Digital Mucous Cysts Volume 30 JAOCDJournal Of The American Osteopathic College Of Dermatology Controversies in the Management of Digital Mucous Cysts Also in this issue: Squamous Cell Carcinoma in Situ Treated with Imiquimod Cream HIV-Associated Kaposi Sarcoma Induced by IRIS Psuedoxanthma Elasticum in Flexural and Non-Flexural Folds last modified on November 19, 2014 3:43 PM JOURNAL OF THE AMERICAN OSTEOPATHIC COLLEGE OF DERMATOLOGY Page 1 JOURNAL OF THE AMERICAN OSTEOPATHIC COLLEGE OF DERMATOLOGY 2013-2014 AOCD OFFICERS PRESIDENT Suzanne Sirota-Rozenberg, DO, FAOCD PRESIDENT-ELECT Rick Lin, DO, FAOCD FIRST VICE-PRESIDENT Alpesh Desai, DO, FAOCD SECOND VICE-PRESIDENT Karthik Krishnamurthy, DO, FAOCD THIRD VICE-PRESIDENT Daniel Ladd, DO, FAOCD Editor-in-Chief SECRETARY-TREASURER Karthik Krishnamurthy, DO Jere J. Mammino, DO, FAOCD TRUSTEES John P. Minni, DO, FAOCD Bryan Sands, DO, FAOCD Danica Alexander, DO, FAOCD Reagan Anderson, DO, FAOCD Sponsors: Michael Whitworth, DO, FAOCD Tracy Favreau, DO, FAOCD Bayer Immediate Past-President AuroraDx David L. Grice, DO, FAOCD EEC Representatives Ranbaxy James Bernard, DO, FAOCD Michael Scott, DO, FAOCD Valeant Finance Committee Representative Steven K. Grekin, DO, FAOCD AOBD Representative Stephen Purcell, DO, FAOCD Executive Director Marsha A. Wise, BS AOCD • 2902 N. Baltimore St. • Kirksville, MO 63501 800-449-2623 • FAX: 660-627-2623 • www.aocd.org COPYRIGHT AND PERMISSION: Written permission must be obtained from the Journal of the American Osteopathic College of Dermatology for copying or reprinting text of more than half a page, tables or figures. Permissions are normally granted contingent upon similar permission from the author(s), inclusion of acknowledgment of the original source, and a payment of $15 per page, table or figure of reproduced material. Permission fees are waived for authors wishing to reproduce their own articles. Request for permission should be directed to JAOCD c/o AOCD, PO Box 7525, Kirksville, MO 63501. Copyright © 2003 by the Journal of the American Osteopathic College of Dermatology Print and layout by: S&S Printing and Graphics LLC, 701 N. Marion St., Kirksville, MO 63501 Copy editing by: Julia Layton, Freelance Writing and Editing Cover image courtesy of Davindra Singh, MD, AvantDerm, 45 Mill St., Toronto, ON Page 2 JOURNAL OF THE AMERICAN OSTEOPATHIC COLLEGE OF DERMATOLOGY JOURNAL OF THE AMERICAN OSTEOPATHIC COLLEGE OF DERMATOLOGY Table of Contents Volume 30 JAOCD Editors ............................................................................................................................................................................................ 4 Letter from the Editor-in-Chief ................................................................................................................................................................... 5 Letter from the Executive Director ............................................................................................................................................................... 6 FEATURE ARTICLE: Controversies in the Management of Digital Mucous Cysts .......................................................................................................................10 Ryan Bhagwandin, BS, Jacqueline Thomas, DO, FAOCD, Scott Greenberg, DO EDITOR’S PICKS: An Atypical Presentation of Squamous Cell Carcinoma in Situ Treated Successfully with Imiquimod Cream .........................................14 Raymond R. Knisley, DO, Angelo A. Petropolis, MD, Vernon T. Mackey, DO HIV-Associated Kaposi Sarcoma Induced by Immune Reconstitution Inflammatory Syndrome Following Antiretroviral Therapy: A Case Report and Review .........................................................................................................................................................................16 Marisa Wolff, DO, Ali Banki, DO, Kenneth P. Abriola, MD, Donna Aiudi, MD, Charles Gropper, MD, Cindy Hoffman, DO, FAOCD Pseudoxanthoma Elasticum in Flexural and Non-Flexural Folds: A Case Presentation and Discussion ....................................................18 Shahrzad Akbary, BS, Joseph Machuzak, DO, FAOCD, Richard Bernert, MD, FASDP ORIGINAL ARTICLES AND CASE REPORTS Review of Reported Cases of Chromhidrosis ..............................................................................................................................................20 Hyunhee Park, DO, Brad Glick, DO, FAOCD Acquired Bilateral Nevus of Ota–like Macules (Hori’s Nevus): A Case Report and Treatment Update .....................................................22 Jamie Hale, DO, David Dorton, DO, Kaisa van der Kooi, MD Dowling-Degos Disease: A Case Report ....................................................................................................................................................24 Megan Joint, DO, Michael Garone, DO, Erica Rushing, MD, Natalie Depcik-Smith, MD, Daniel Hurd, DO, FAOCD An Unusual Case of Henoch-Schönlein Purpura in an Elderly Male .........................................................................................................26 Jeffrey Kushner, DO, David Posnick, DO, Joan M. Mones, DO, Adriana Ros, DO, FAOCD PLEVA in an Adult Patient with an Unclear HSV Association .................................................................................................................29 Alyson Snyder, BS, G. Trey Haunson, DO, Michael Conroy, MD, Daniel S. Hurd, DO, FAOCD Large Cerebriform Eccrine Porocarcinoma: A Case Report .......................................................................................................................32 Robert Lin, DO, Alpesh Desai, DO, FAOCD An Unusual Clinical Presentation of Palisaded Neutrophilic and Granulomatous Dermatitis ...................................................................34 Marina Matatova, DO Scleredema Diabeticorum: A Case Report and Review of Literature .........................................................................................................36 Donna Tran, DO, Navid Nami, DO The bug beneath the bathing suit: A case report and discussion of seabather’s eruption versus cutaneous larva migrans ............................38 Andrew Jensen, BS, Marcus Goodman, DO, FAOCD Segmental Neurofibromatosis: A Report of Two Cases and Review of a Rare and Inconspicuous Subset of a Common Genodermatosis ...................................................................................................................................................................40 Sarah Ferrer-Bruker, DO, Christina Steinmetz, DO, Brent Schillinger, MD, Andleeb Usmani, DO Increased Frequency of Histologic Diagnosis of Syphilis in Older Individuals During the Last Five Years ...............................................44 Jamie Groh, DO, Willmar D. Patino, MD JOURNAL OF THE AMERICAN OSTEOPATHIC COLLEGE OF DERMATOLOGY Page 3 Editor-In-Chief Founding Editor Assistant Editor Karthik Krishnamurthy, DO Jay Gottleib, DO Julia Layton, BA, MFA Associate Editors Derrick Adams, DO Aaron Bruce, DO Michael Scott, DO Scott Wickless, DO Red Bluff, CA Bozeman, Montana Seattle, WA Dallas, Texas Editorial Board Sami Abbasi, DO Marcus Goodman, DO Angela Leo, DO John Perrotto, DO Brownstown, MI Roswell, GA New York, NY West Palm Beach, FL Brett Bender, DO Melinda Greenfield, DO Scott Lim, DO Andrew Racette, DO Farmington Hills, MI Albany. GA Erie, PA Phoenix, AZ Ryan Carlson, DO Denise Guevara, DO Chava Lustig, DO Richard Rudnicki, DO Hilliard, OH Weston, FL Weston, FL Mesquite, TX Igor Chaplik, DO Andrew Hanly, MD Jere Mammino, DO Amara Sayed, DO Aventura, FL Miami, FL Winter Springs, FL San Marcos, TX Michael P. Conroy, MD Joel Harris, DO John Minni, DO Joseph Brant Schneider, DO Columbus, OH Madison Heights, MI Port St. Lucie, FL Shawnee Mission, KS John Coppola Heather Higgins, DO Tony Nakhla, DO Gregg Severs, DO Ormond Beach, FL Troy, MI Orange County, CA Scranton, PA Matthew Elias, DO David Horowitz, DO Navid Nami, DO Sean Stephenson, DO Lighthouse Point, FL Torrence, CA Newport Beach, CA Troy, MI Michelle Foley, DO Matt Leavitt, DO Jon Keeling, DO Jacqueline Thomas, DO Ormond Beach, FL Maitland, FL Lexington, KY Fort Lauderdale, FL Brad Glick, DO Mark Lebwohl, MD Dimitria Papadopoulos, DO Jim Towry, DO Margate, FL New York, NY Bellmore, NY Ocala, FL Page 4 JAOCD EDITORS LETTER FROM THE EDITOR-IN-CHIEF Karthik Krishnamurthy, DO, FAOCD Editor-in-Chief Dear Readers, Case reports are a cornerstone in the development and dissemination of information in medicine; however, in recent years, there has been a noticeable decrease in the amount of space available in journals to publish this type of manuscript. More space is being devoted to evidence-based articles and industry-driven data. Wikipedia states: “A case report is generally considered a type of anecdotal evidence. Given their intrinsic methodological limitations, including lack of statistical sampling, case reports are placed at the foot of the hierarchy of clinical evidence, together with case series. Nevertheless, case reports do have genuinely useful roles in medical research and evidence-based medicine. In particular, they have facilitated recognition of new diseases and adverse effects of treatments.” Some examples of discoveries directly resulting from case reports: • The first heart transplant • Thalidomide and teratogenicity • Hallmark findings in HIV/AIDS Our specialty is fortunate to still recognize the utility and importance of case reporting in presenting new findings, communicating novel therapeutic
Load more

Recommended publications
  • Seborrheic Dermatitis: an Overview ROBERT A
    Seborrheic Dermatitis: An Overview ROBERT A. SCHWARTZ, M.D., M.P.H., CHRISTOPHER A. JANUSZ, M.D., and CAMILA K. JANNIGER, M.D. University of Medicine and Dentistry at New Jersey-New Jersey Medical School, Newark, New Jersey Seborrheic dermatitis affects the scalp, central face, and anterior chest. In adolescents and adults, it often presents as scalp scaling (dandruff). Seborrheic dermatitis also may cause mild to marked erythema of the nasolabial fold, often with scaling. Stress can cause flare-ups. The scales are greasy, not dry, as commonly thought. An uncommon generalized form in infants may be linked to immunodeficiencies. Topical therapy primarily consists of antifungal agents and low-potency steroids. New topical calcineurin inhibitors (immunomodulators) sometimes are administered. (Am Fam Physician 2006;74:125-30. Copyright © 2006 American Academy of Family Physicians.) eborrheic dermatitis can affect patients levels, fungal infections, nutritional deficits, from infancy to old age.1-3 The con- neurogenic factors) are associated with the dition most commonly occurs in condition. The possible hormonal link may infants within the first three months explain why the condition appears in infancy, S of life and in adults at 30 to 60 years of age. In disappears spontaneously, then reappears adolescents and adults, it usually presents as more prominently after puberty. A more scalp scaling (dandruff) or as mild to marked causal link seems to exist between seborrheic erythema of the nasolabial fold during times dermatitis and the proliferation of Malassezia of stress or sleep deprivation. The latter type species (e.g., Malassezia furfur, Malassezia tends to affect men more often than women ovalis) found in normal dimorphic human and often is precipitated by emotional stress.
    [Show full text]
  • Scalp Eczema Factsheet the Scalp Is an Area of the Body That Can Be Affected by Several Types of Eczema
    12 Scalp eczema factsheet The scalp is an area of the body that can be affected by several types of eczema. The scalp may be dry, itchy and scaly in a chronic phase and inflamed (red), weepy and painful in an acute (eczema flare) phase. Aside from eczema, there are a number of reasons why the scalp can become dry and itchy (e.g. psoriasis, fungal infection, ringworm, head lice etc.), so it is wise to get a firm diagnosis if there is uncertainty. Types of eczema • Hair clips and headgear – especially those containing that affect the scalp rubber or nickel. Seborrhoeic eczema (dermatitis) is one of the most See the NES booklet on Contact Dermatitis for more common types of eczema seen on the scalp and hairline. details. It can affect babies (cradle cap), children and adults. The Irritant contact dermatitis is a type of eczema that skin appears red and scaly and there is often dandruff as occurs when the skin’s surface is irritated by a substance well, which can vary in severity. There may also be a rash that causes the skin to become dry, red and itchy. on other parts of the face, such as around the eyebrows, For example, shampoos, mousses, hair gels, hair spray, eyelids and sides of the nose. Seborrhoeic eczema can perm solution and fragrance can all cause irritant contact become infected. See the NES factsheets on Adult dermatitis. See the NES booklet on Contact Dermatitis for Seborrhoeic Dermatitis and Infantile Seborrhoeic more details. Dermatitis and Cradle Cap for more details.
    [Show full text]
  • Skin Conditions and Related Need for Medical Care Among Persons 1=74 Years United States, 1971-1974
    Data from the Series 11 NATIONAL HEALTH SURVEY Number 212 Skin Conditions and Related Need for Medical Care Among Persons 1=74 Years United States, 1971-1974 DHEW Publication No. (PHS) 79-1660 U.S, DEPARTMENT OF HEALTH, EDUCATION, AND WELFARE Public Health Service Office of the Assistant Secretary for Health National Center for Health Statistics Hyattsville, Md. November 1978 NATIONAL CENTIER FOR HEALTH STATISTICS DOROTHY P. RICE, Director ROBERT A. ISRAEL, Deputy Director JACOB J. FELDAMN, Ph.D., Associate Director for Amdy.sis GAIL F. FISHER, Ph.D., Associate Director for the Cooperative Health Statistics System ELIJAH L. WHITE, Associate Director for Data Systems JAMES T. BAIRD, JR., Ph.D., Associate Director for International Statistics ROBERT C. HUBER, Associate Director for Managewzent MONROE G. SIRKEN, Ph.D., Associate Director for Mathematical Statistics PETER L. HURLEY, Associate Director for Operations JAMES M. ROBEY, Ph.D., Associate Director for Program Development PAUL E. LEAVERTON, Ph.D., Associate Director for Research ALICE HAYWOOD,, Information Officer DIVISION OF HEALTH EXAMINATION STATISTICS MICHAEL A. W. HATTWICK, M.D., Director JEAN ROEERTS, Chiej, Medical Statistics Branch ROBERT S. MURPHY, Chiej Survey Planning and Development Branch DIVISION OF OPERATIONS HENRY MILLER, ChieJ Health -Examination Field Operations Branch COOPERATION OF THE U.S. BUREAU OF THE CENSUS Under the legislation establishing the National Health Survey, the Public Health Service is authorized to use, insofar as possible, the sesw?icesor facilities of other Federal, State, or private agencies. In accordance with specifications established by the National Center for Health Statis- tics, the U.S. Bureau of the Census participated in the design and selection of the sample and carried out the household interview stage of :the data collection and certain parts of the statis- tical processing.
    [Show full text]
  • Therapeutic Use of Botulinum Neurotoxins in Dermatology: Systematic Review
    toxins Review Therapeutic Use of Botulinum Neurotoxins in Dermatology: Systematic Review Emanuela Martina †, Federico Diotallevi †, Giulia Radi †, Anna Campanati * and Annamaria Offidani Dermatological Clinic, Department of Clinical and Molecular Sciences, Polytechnic Marche University, 60020 Ancona, Italy; [email protected] (E.M.); [email protected] (F.D.); [email protected] (G.R.); annamaria.offi[email protected] (A.O.) * Correspondence: [email protected] † These authors equally contributed to the manuscript. Abstract: Botulinum toxin is a superfamily of neurotoxins produced by the bacterium Clostridium Botulinum with well-established efficacy and safety profile in focal idiopathic hyperhidrosis. Recently, botulinum toxins have also been used in many other skin diseases, in off label regimen. The objective of this manuscript is to review and analyze the main therapeutic applications of botulinum toxins in skin diseases. A systematic review of the published data was conducted, following Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines. Botulinum toxins present several label and off-label indications of interest for dermatologists. The best-reported evidence concerns focal idiopathic hyperhidrosis, Raynaud phenomenon, suppurative hidradenitis, Hailey–Hailey disease, epidermolysis bullosa simplex Weber–Cockayne type, Darier’s disease, pachyonychia congenita, aquagenic keratoderma, alopecia, psoriasis, notalgia paresthetica, facial erythema and flushing, and oily skin.
    [Show full text]
  • An Ayurvedic Approach in the Management of Darunaka (Seborrhoeic Dermatitis): a Case Study
    International Journal of Health Sciences and Research Vol.10; Issue: 4; April 2020 Website: www.ijhsr.org Case Study ISSN: 2249-9571 An Ayurvedic Approach in the Management of Darunaka (Seborrhoeic Dermatitis): A Case Study Kumari Archana1, D.B. Vaghela2 1PhD Scholar, 2Assosiate Professor, Shalakyatantra Department, Institute for Post Graduate Teaching and Research in Ayurveda, Gujarat Ayurved University, Jamnagar, India. Corresponding Author: Kumari Archana ABSTRACT Darunaka is a Kapalagataroga but Acharya Sushruta has described this disease as a Kshudraroga due to the vitiation of Vata and Kapha Doshas with symptoms like Kandu (itching on scalp), Keshachyuti (falling of hair), Swapa(abnormalities of touch sensation on scalp), Rookshata (roughness or dryness of the scalp) and Twaksphutana (breaking or cracking of the scalp skin). Seborrhoeic Dermatitis, an irritative disease of the scalp in which shedding of dead tissue from the scalp with itching sensation is the cardinal feature which can be correlated with Darunaka. It has been reported that Seborrhoeic Dermatitisaffect about 4% of the population, and dandruff (which is mild seborrhoeic dermatitis of the scalp) can affect almost half of all adults. It can start at any time after puberty and is slightly commoner in men. It can result in social or self-esteem problems. A 56 yr old male patient from Jamnagar came to OPD of ShalakyaTantra, with chief complaint of ShirahKandu (itching on scalp), Rukshata (dryness on scalp), TwakSphutana (cracks in the skin) with blood mixed watery oozing, KeshaChyuti (hair fall). In this case Ayurvedic formulation of ArogyavardhiniVati (orally), TriphalaChurna (orally), ManjisthadiKwatha (orally), YashtiChurna mixed with coconut hair oil as external application followed by washing the hair with a Kwatha (decoction) of TriphalaYavkut and ShuddhaTankana.
    [Show full text]
  • Clinical Dermatology Notice
    This page intentionally left blank Clinical Dermatology Notice Medicine is an ever-changing science. As new research and clinical experience broaden our knowledge, changes in treatment and drug therapy are required. The editors and the publisher of this work have checked with sources believed to be reliable in their efforts to provide information that is complete and generally in accord with the standards accepted at the time of publication. However, in view of the possibility of human error or changes in medical sciences, neither the editors nor the publisher nor any other party who has been involved in the preparation or publication of this work warrants that the information contained herein is in every respect accurate or complete, and they disclaim all responsibility for any errors or omissions or for the results obtained from use of such information contained in this work. Readers are encouraged to confirm the information contained herein with other sources. For example and in particular, readers are advised to check the product information sheet included in the package of each drug they plan to administer to be certain that the information contained in this work is accurate and that changes have not been made in the recommended dose or in the contraindications for administration. This recommendation is of particular importance in connection with new or infrequently used drugs. a LANGE medical book Clinical Dermatology Carol Soutor, MD Clinical Professor Department of Dermatology University of Minnesota Medical School Minneapolis, Minnesota Maria K. Hordinsky, MD Chair and Professor Department of Dermatology University of Minnesota Medical School Minneapolis, Minnesota New York Chicago San Francisco Lisbon London Madrid Mexico City Milan New Delhi San Juan Seoul Singapore Sydney Toronto Copyright © 2013 by McGraw-Hill Education, LLC.
    [Show full text]
  • Nonpharmacologic Treatment of Rosacea Corporate Medical Policy Policy
    Nonpharmacologic Treatment of Rosacea Corporate Medical Policy File Name: Nonpharmacologic Treatment of Rosacea File Code: UM.SURG.11 Last Review: 07/2020 Next Review: 07/2021 Effective Date: 11/01/2020 Description/Summary Rosacea is a chronic, inflammatory skin condition without a known cure; the goal of treatment is symptom management. Nonpharmacologic treatments, including laser and light therapy, dermabrasion, and others, are proposed for patients who do not want to use or are unresponsive to pharmacologic therapy. For individuals who have rosacea who receive nonpharmacologic treatment (e.g., laser therapy, light therapy, dermabrasion, others) the evidence includes several small randomized, split -face design trials. Relevant outcomes are symptoms, change in disease status, and treatment-related morbidity. None of the randomized controlled trials (RCTs) included a comparison group of patients receiving a placebo or pharmacologic treatment and therefore, these studies do not offer definitive evidence on the efficacy of nonpharmacologic treatment compared with alternative treatment options. There is a need for additional RCTs comparing nonpharmacologic treatments with placebo controls and with pharmacologic treatments. The evidence is insufficient to determine the effects of the technology on health outcomes. Policy Coding Information Click the links below for attachments, coding tables & instructions. Attachment I- Code Table & Instructions Attachment II – ICD-10- CM Coding Table When a service is considered investigational Nonpharmacologic treatment of rosacea, including but not limited to laser and light therapy, dermabrasion, chemical peels, surgical debulking and electrosurgery, is considered investigational. Reference Resources 1. BlueCross and BlueShield Association MPRM 2.01.71 Nonpharmacologic Treatment of Page 1 of 4 Medical Policy Number: UM.SURG.11 Rosacea.
    [Show full text]
  • Therapies for Common Cutaneous Fungal Infections
    MedicineToday 2014; 15(6): 35-47 PEER REVIEWED FEATURE 2 CPD POINTS Therapies for common cutaneous fungal infections KENG-EE THAI MB BS(Hons), BMedSci(Hons), FACD Key points A practical approach to the diagnosis and treatment of common fungal • Fungal infection should infections of the skin and hair is provided. Topical antifungal therapies always be in the differential are effective and usually used as first-line therapy, with oral antifungals diagnosis of any scaly rash. being saved for recalcitrant infections. Treatment should be for several • Topical antifungal agents are typically adequate treatment weeks at least. for simple tinea. • Oral antifungal therapy may inea and yeast infections are among the dermatophytoses (tinea) and yeast infections be required for extensive most common diagnoses found in general and their differential diagnoses and treatments disease, fungal folliculitis and practice and dermatology. Although are then discussed (Table). tinea involving the face, hair- antifungal therapies are effective in these bearing areas, palms and T infections, an accurate diagnosis is required to ANTIFUNGAL THERAPIES soles. avoid misuse of these or other topical agents. Topical antifungal preparations are the most • Tinea should be suspected if Furthermore, subsequent active prevention is commonly prescribed agents for dermatomy- there is unilateral hand just as important as the initial treatment of the coses, with systemic agents being used for dermatitis and rash on both fungal infection. complex, widespread tinea or when topical agents feet – ‘one hand and two feet’ This article provides a practical approach fail for tinea or yeast infections. The pharmacol- involvement. to antifungal therapy for common fungal infec- ogy of the systemic agents is discussed first here.
    [Show full text]
  • Stretch Marks): Prevention and Therapy of Striae Rubrae and Albae
    DOI: 10.1111/jdv.13223 JEADV REVIEW ARTICLE Topical management of striae distensae (stretch marks): prevention and therapy of striae rubrae and albae S. Ud-Din,1,2 D. McGeorge,3 A. Bayat1,2,* 1Plastic and Reconstructive Surgery Research, Manchester Institute of Biotechnology, University of Manchester, Manchester, UK 2Centre for Dermatology, Institute of Inflammation and Repair, Faculty of Medical and Human Sciences, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK 3Grosvenor Nuffield Hospital, Chester, UK *Correspondence: A. Bayat. E-mail: [email protected] Abstract Striae distensae (SD) are common dermal lesions, with significant physical and psychological impact. Many therapeutic modalities are available but none can completely eradicate SD. The most common therapy is the application of topicals used both therapeutically and prophylactically. Even though there are many commercially available topical products, not all have sufficient level of evidence to support their continued use in SD. The aim here was to assess the evidence for the use of topicals in SD and to propose a structured approach in managing SD. A systematic search of published literature and manufacturer website information for topicals in SD was carried out. The results showed that there are few studies (n = 11) which investigate the efficacy of topicals in management of SD. Trofolastin and Alphastria creams demonstrated level-2 evidence of positive results for their prophylactic use in SD. Additionally, tretinoin used therapeutically showed varying results whilst cocoa butter and olive oil did not demonstrate any effect. Overall, there is a distinct lack of evi- dence for each topical formulation. The majority of topicals failed to mention their effect on early vs.
    [Show full text]
  • Cutaneous Manifestations of Systemic Disease
    Cutaneous Manifestations of Systemic Disease Dr. Lloyd J. Cleaver D.O. FAOCD FAAD Northeast Regional Medical Center A.T.Still University/KCOM Assistant Vice President/Professor ACOI Board Review Disclosure I have no financial relationships to disclose I will not discuss off label use and/or investigational use in my presentation I do not have direct knowledge of AOBIM questions I have been granted approvial by the AOA to do this board review Dermatology on the AOBIM ”1-4%” of exam is Dermatology Table of Test Specifications is unavailable Review Syllabus for Internal Medicine Large amount of information Cutaneous Multisystem Cutaneous Connective Tissue Conditions Connective Tissue Diease Discoid Lupus Erythematosus Subacute Cutaneous LE Systemic Lupus Erythematosus Scleroderma CREST Syndrome Dermatomyositis Lupus Erythematosus Spectrum from cutaneous to severe systemic involvement Discoid LE (DLE) / Chronic Cutaneous Subacute Cutaneous LE (SCLE) Systemic LE (SLE) Cutaneous findings common in all forms Related to autoimmunity Discoid LE (Chronic Cutaneous LE) Primarily cutaneous Scaly, erythematous, atrophic plaques with sharp margins, telangiectasias and follicular plugging Possible elevated ESR, anemia or leukopenia Progression to SLE only 1-2% Heals with scarring, atrophy and dyspigmentation 5% ANA positive Discoid LE (Chronic Cutaneous LE) Scaly, atrophic plaques with defined margins Discoid LE (Chronic Cutaneous LE) Scaly, erythematous plaques with scarring, atrophy, dyspigmentation DISCOID LUPUS Subacute Cutaneous
    [Show full text]
  • Copyrighted Material
    1 Index Note: Page numbers in italics refer to figures, those in bold refer to tables and boxes. References are to pages within chapters, thus 58.10 is page 10 of Chapter 58. A definition 87.2 congenital ichthyoses 65.38–9 differential diagnosis 90.62 A fibres 85.1, 85.2 dermatomyositis association 88.21 discoid lupus erythematosus occupational 90.56–9 α-adrenoceptor agonists 106.8 differential diagnosis 87.5 treatment 89.41 chemical origin 130.10–12 abacavir disease course 87.5 hand eczema treatment 39.18 clinical features 90.58 drug eruptions 31.18 drug-induced 87.4 hidradenitis suppurativa management definition 90.56 HLA allele association 12.5 endocrine disorder skin signs 149.10, 92.10 differential diagnosis 90.57 hypersensitivity 119.6 149.11 keratitis–ichthyosis–deafness syndrome epidemiology 90.58 pharmacological hypersensitivity 31.10– epidemiology 87.3 treatment 65.32 investigations 90.58–9 11 familial 87.4 keratoacanthoma treatment 142.36 management 90.59 ABCA12 gene mutations 65.7 familial partial lipodystrophy neutral lipid storage disease with papular elastorrhexis differential ABCC6 gene mutations 72.27, 72.30 association 74.2 ichthyosis treatment 65.33 diagnosis 96.30 ABCC11 gene mutations 94.16 generalized 87.4 pityriasis rubra pilaris treatment 36.5, penile 111.19 abdominal wall, lymphoedema 105.20–1 genital 111.27 36.6 photodynamic therapy 22.7 ABHD5 gene mutations 65.32 HIV infection 31.12 psoriasis pomade 90.17 abrasions, sports injuries 123.16 investigations 87.5 generalized pustular 35.37 prepubertal 90.59–64 Abrikossoff
    [Show full text]
  • Heat Dermabrasion of Congenital Nevi As a Simple, Innovative Technique
    Our Dermatology Online Brief Report HHeateat ddermabrasionermabrasion ooff ccongenitalongenital nnevievi aass a ssimple,imple, iinnovativennovative ttechniqueechnique Khalifa Sharquie1, Raed I Jabbar2 1Department of Dermatology, College of Medicine, University of Baghdad, Medical City Teaching Hospital, Baghdad, Iraq, 2Department of Dermatology, Fallujah Teaching Hospital, Al-Anbar Health Directorate, Anbar, Iraq Corresponding author: Prof. Khalifa E Sharquie, MD PhD, E-mail: [email protected] ABSTRACT Background: Congenital nevi are a relatively common dermatological problem that carries a risk of malignant transformation. Patients and Methods: The following is an interventional study in which five patients with congenital melanocytic nevi were enrolled, 3 (60%) females and 2 (40%) males. After local anesthesia, heat dermabrasion was performed with a diathermal needle until complete debulking was achieved and bleeding points appeared. Follow-up was done every two months for four months. Results: The location of the nevi in all cases was the face, while the size was variable, ranging from 1 to 17 cm. Erythema was observed on the sites of the removed nevi after two weeks and then gradually went to normal during the follow-up period, leaving minimal scarring. Complications were absent and no relapses were observed during the follow-up period. Conclusion: This is a simple, easy, and innovative technique that employs heat dermabrasion and, thus, avoids excision and suturing with or without grafting or flaps. Key words: Congenital melanocytic nevus; Heat dermabrasion; Malignant melanoma INTRODUCTION Moreover, there is an increased risk of developing malignant melanoma (MM) in patients with CMN, Congenital melanocytic nevi (CMN) are either present especially with larger CMNs [5]. Large and giant at birth or appear in the first several weeks of life, with lesions have a high risk of developing MM, but small an incidence of 1% to 2% in newborns [1].
    [Show full text]